Intravitreal (IVT) Injectables Market Report

Global Intravitreal (IVT) Injectables Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 26, 2022
  • PAGES：236
  • REPORT CODE：GMM779699
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Intravitreal (IVT) Injectables market report explains the definition, types, applications, major countries, and major players of the Intravitreal (IVT) Injectables market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • ThromboGenics

    • Novartis

    • Regeneron Pharmaceuticals

    • Alimera Sciences

    • Bausch & Lomb

    • Allergan

    • Bristol-Myers Squibb

    By Type:

    • Anti-VEGF

    • Corticosteroids

    • Antibiotics

    • Antivirals

    • Antifungals

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Drug Stores

    • Mail Order Pharmacies

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Intravitreal (IVT) Injectables Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Intravitreal (IVT) Injectables Outlook to 2028- Original Forecasts

    • 2.2 Intravitreal (IVT) Injectables Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Intravitreal (IVT) Injectables Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Intravitreal (IVT) Injectables Market- Recent Developments

    • 6.1 Intravitreal (IVT) Injectables Market News and Developments

    • 6.2 Intravitreal (IVT) Injectables Market Deals Landscape

    7 Intravitreal (IVT) Injectables Raw Materials and Cost Structure Analysis

    • 7.1 Intravitreal (IVT) Injectables Key Raw Materials

    • 7.2 Intravitreal (IVT) Injectables Price Trend of Key Raw Materials

    • 7.3 Intravitreal (IVT) Injectables Key Suppliers of Raw Materials

    • 7.4 Intravitreal (IVT) Injectables Market Concentration Rate of Raw Materials

    • 7.5 Intravitreal (IVT) Injectables Cost Structure Analysis

      • 7.5.1 Intravitreal (IVT) Injectables Raw Materials Analysis

      • 7.5.2 Intravitreal (IVT) Injectables Labor Cost Analysis

      • 7.5.3 Intravitreal (IVT) Injectables Manufacturing Expenses Analysis

    8 Global Intravitreal (IVT) Injectables Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Intravitreal (IVT) Injectables Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Intravitreal (IVT) Injectables Export by Region (Top 10 Countries) (2017-2028)

    9 Global Intravitreal (IVT) Injectables Market Outlook by Types and Applications to 2022

    • 9.1 Global Intravitreal (IVT) Injectables Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Anti-VEGF Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Corticosteroids Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Antibiotics Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Antivirals Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Antifungals Consumption and Growth Rate (2017-2022)

    • 9.2 Global Intravitreal (IVT) Injectables Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Drug Stores Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Mail Order Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Intravitreal (IVT) Injectables Market Analysis and Outlook till 2022

    • 10.1 Global Intravitreal (IVT) Injectables Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.2.2 Canada Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.2.3 Mexico Intravitreal (IVT) Injectables Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.3.2 UK Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.3.3 Spain Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.3.4 Belgium Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.3.5 France Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.3.6 Italy Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.3.7 Denmark Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.3.8 Finland Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.3.9 Norway Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.3.10 Sweden Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.3.11 Poland Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.3.12 Russia Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.3.13 Turkey Intravitreal (IVT) Injectables Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.4.2 Japan Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.4.3 India Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.4.4 South Korea Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.4.5 Pakistan Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.4.6 Bangladesh Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.4.7 Indonesia Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.4.8 Thailand Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.4.9 Singapore Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.4.10 Malaysia Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.4.11 Philippines Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.4.12 Vietnam Intravitreal (IVT) Injectables Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.5.2 Colombia Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.5.3 Chile Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.5.4 Argentina Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.5.5 Venezuela Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.5.6 Peru Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.5.7 Puerto Rico Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.5.8 Ecuador Intravitreal (IVT) Injectables Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.6.2 Kuwait Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.6.3 Oman Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.6.4 Qatar Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Intravitreal (IVT) Injectables Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.7.2 South Africa Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.7.3 Egypt Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.7.4 Algeria Intravitreal (IVT) Injectables Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Intravitreal (IVT) Injectables Consumption (2017-2022)

      • 10.8.2 New Zealand Intravitreal (IVT) Injectables Consumption (2017-2022)

    11 Global Intravitreal (IVT) Injectables Competitive Analysis

    • 11.1 ThromboGenics

      • 11.1.1 ThromboGenics Company Details

      • 11.1.2 ThromboGenics Intravitreal (IVT) Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 ThromboGenics Intravitreal (IVT) Injectables Main Business and Markets Served

      • 11.1.4 ThromboGenics Intravitreal (IVT) Injectables Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Novartis

      • 11.2.1 Novartis Company Details

      • 11.2.2 Novartis Intravitreal (IVT) Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Novartis Intravitreal (IVT) Injectables Main Business and Markets Served

      • 11.2.4 Novartis Intravitreal (IVT) Injectables Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Regeneron Pharmaceuticals

      • 11.3.1 Regeneron Pharmaceuticals Company Details

      • 11.3.2 Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Main Business and Markets Served

      • 11.3.4 Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Alimera Sciences

      • 11.4.1 Alimera Sciences Company Details

      • 11.4.2 Alimera Sciences Intravitreal (IVT) Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Alimera Sciences Intravitreal (IVT) Injectables Main Business and Markets Served

      • 11.4.4 Alimera Sciences Intravitreal (IVT) Injectables Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Bausch & Lomb

      • 11.5.1 Bausch & Lomb Company Details

      • 11.5.2 Bausch & Lomb Intravitreal (IVT) Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Bausch & Lomb Intravitreal (IVT) Injectables Main Business and Markets Served

      • 11.5.4 Bausch & Lomb Intravitreal (IVT) Injectables Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Allergan

      • 11.6.1 Allergan Company Details

      • 11.6.2 Allergan Intravitreal (IVT) Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Allergan Intravitreal (IVT) Injectables Main Business and Markets Served

      • 11.6.4 Allergan Intravitreal (IVT) Injectables Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Bristol-Myers Squibb

      • 11.7.1 Bristol-Myers Squibb Company Details

      • 11.7.2 Bristol-Myers Squibb Intravitreal (IVT) Injectables Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Bristol-Myers Squibb Intravitreal (IVT) Injectables Main Business and Markets Served

      • 11.7.4 Bristol-Myers Squibb Intravitreal (IVT) Injectables Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Intravitreal (IVT) Injectables Market Outlook by Types and Applications to 2028

    • 12.1 Global Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Anti-VEGF Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Antivirals Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Antifungals Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Mail Order Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Intravitreal (IVT) Injectables Market Analysis and Outlook to 2028

    • 13.1 Global Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.2.2 Canada Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.3.2 UK Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.3.3 Spain Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.3.5 France Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.3.6 Italy Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.3.8 Finland Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.3.9 Norway Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.3.11 Poland Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.3.12 Russia Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.4.2 Japan Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.4.3 India Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.5.3 Chile Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.5.6 Peru Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.6.3 Oman Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Intravitreal (IVT) Injectables Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Intravitreal (IVT) Injectables

    • Figure of Intravitreal (IVT) Injectables Picture

    • Table Global Intravitreal (IVT) Injectables Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Intravitreal (IVT) Injectables Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Anti-VEGF Consumption and Growth Rate (2017-2022)

    • Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)

    • Figure Global Antibiotics Consumption and Growth Rate (2017-2022)

    • Figure Global Antivirals Consumption and Growth Rate (2017-2022)

    • Figure Global Antifungals Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Stores Consumption and Growth Rate (2017-2022)

    • Figure Global Mail Order Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Intravitreal (IVT) Injectables Consumption by Country (2017-2022)

    • Table North America Intravitreal (IVT) Injectables Consumption by Country (2017-2022)

    • Figure United States Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Canada Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Mexico Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Table Europe Intravitreal (IVT) Injectables Consumption by Country (2017-2022)

    • Figure Germany Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure UK Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Spain Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Belgium Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure France Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Italy Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Denmark Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Finland Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Norway Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Sweden Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Poland Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Russia Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Turkey Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Table APAC Intravitreal (IVT) Injectables Consumption by Country (2017-2022)

    • Figure China Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Japan Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure India Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure South Korea Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Thailand Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Singapore Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Philippines Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Table South America Intravitreal (IVT) Injectables Consumption by Country (2017-2022)

    • Figure Brazil Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Colombia Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Chile Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Argentina Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Peru Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Table GCC Intravitreal (IVT) Injectables Consumption by Country (2017-2022)

    • Figure Bahrain Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Oman Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Qatar Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Table Africa Intravitreal (IVT) Injectables Consumption by Country (2017-2022)

    • Figure Nigeria Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure South Africa Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Egypt Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure Algeria Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Table Oceania Intravitreal (IVT) Injectables Consumption by Country (2017-2022)

    • Figure Australia Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Intravitreal (IVT) Injectables Consumption and Growth Rate (2017-2022)

    • Table ThromboGenics Company Details

    • Table ThromboGenics Intravitreal (IVT) Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table ThromboGenics Intravitreal (IVT) Injectables Main Business and Markets Served

    • Table ThromboGenics Intravitreal (IVT) Injectables Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Intravitreal (IVT) Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Intravitreal (IVT) Injectables Main Business and Markets Served

    • Table Novartis Intravitreal (IVT) Injectables Product Portfolio

    • Table Regeneron Pharmaceuticals Company Details

    • Table Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Main Business and Markets Served

    • Table Regeneron Pharmaceuticals Intravitreal (IVT) Injectables Product Portfolio

    • Table Alimera Sciences Company Details

    • Table Alimera Sciences Intravitreal (IVT) Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alimera Sciences Intravitreal (IVT) Injectables Main Business and Markets Served

    • Table Alimera Sciences Intravitreal (IVT) Injectables Product Portfolio

    • Table Bausch & Lomb Company Details

    • Table Bausch & Lomb Intravitreal (IVT) Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bausch & Lomb Intravitreal (IVT) Injectables Main Business and Markets Served

    • Table Bausch & Lomb Intravitreal (IVT) Injectables Product Portfolio

    • Table Allergan Company Details

    • Table Allergan Intravitreal (IVT) Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Intravitreal (IVT) Injectables Main Business and Markets Served

    • Table Allergan Intravitreal (IVT) Injectables Product Portfolio

    • Table Bristol-Myers Squibb Company Details

    • Table Bristol-Myers Squibb Intravitreal (IVT) Injectables Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Intravitreal (IVT) Injectables Main Business and Markets Served

    • Table Bristol-Myers Squibb Intravitreal (IVT) Injectables Product Portfolio

    • Figure Global Anti-VEGF Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antivirals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antifungals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Mail Order Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intravitreal (IVT) Injectables Consumption Forecast by Country (2022-2028)

    • Table North America Intravitreal (IVT) Injectables Consumption Forecast by Country (2022-2028)

    • Figure United States Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Intravitreal (IVT) Injectables Consumption Forecast by Country (2022-2028)

    • Figure Germany Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Intravitreal (IVT) Injectables Consumption Forecast by Country (2022-2028)

    • Figure China Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Intravitreal (IVT) Injectables Consumption Forecast by Country (2022-2028)

    • Figure Brazil Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Intravitreal (IVT) Injectables Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Intravitreal (IVT) Injectables Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Intravitreal (IVT) Injectables Consumption Forecast by Country (2022-2028)

    • Figure Australia Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Intravitreal (IVT) Injectables Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US